All UK & Rest of Europe articles – Page 15
-
NewsHigh speed atomic force microscopy studies provide insights into influenza A viral replication
Researchers used high-speed atomic force microscopy and electron microscopy to pin down the conformational dynamics of recombinant Influenza A genomes (or rRNPs) during RNA synthesis.
-
OpinionWheat straw and muncipal waste - how next generation biofuels can save the world
With greenhouse gas emissions peaking, the search for renewables is intensifying. AMI Healthy Land Scientific Advisory Group member Juan Luis Ramos and his colleagues Estrella Duque and Patricia Godoy take a look at the future of biofuels.
-
NewsRVC awarded funding to investigate how methane-producing microbes colonise young calves
The Royal Veterinary College has been awarded £1,200,000 to explore how methane-producing microorganisms colonise the gastro-intestinal tract of calves in the first six weeks of life and how they impact the developing immune system.
-
NewsResearchers discover source of deadly fungal infections in bone marrow transplant patients
Scientists have found that heteroresistance is the reason a small number of transplant patients developed bloodstream infections, despite receiving prophylaxis with the antifungal drug micafungin.
-
NewsConsumers open to animal-free dairy products made with precision fermentation
Companies and institutes are currently working on biotechnological processes for the production of dairy products without the use of cows: In so-called precision fermentation, egg and milk proteins are produced with the help of bacteria, yeasts or other fungi. This results in foods such as milk or cheese with a ...
-
NewsNew study highlights scale and impact of long COVID
A wide range of biological mechanisms are involved in long Covid, including persistence of the original virus in the body, disruption of the normal immune response, and microscopic blood clotting, even in some people who had only mild initial infections.
-
NewsResearchers make breakthrough in bid to develop vaccines and drugs for neglected tropical disease
Scientists have developed a new, safe and effective way to infect volunteers with the parasite that causes leishmaniasis and measure the body’s immune response, bringing a vaccine for the neglected tropical disease a step closer.
-
NewsBiocides are a useful tool to combat antibiotic resistance but appropriate use is vital, scientists suggest
A recent review in Sustainable Microbiology discusses how the use of biocides can promote well-being but must only be used when there are clear benefits.
-
NewsClimate anomalies may play a major role in driving cholera pandemics
New research suggests that an El Niño event may have aided the establishment of a novel cholera strain during an early 20th-century pandemic, suggesting climate anomalies could create opportunities for the emergence of new cholera strains.
-
NewsWarming stops tiny organisms working together
The single-celled organism Paramecium bursaria can absorb and host algae (Chlorella spp), providing benefits for both, but when scientists made the water 5°C warmer, the partnership stopped working – and the algae may even become parasitic.
-
NewsValneva and LimmaTech team up to accelerate tetravalent Shigella vaccine candidate
Valneva SE and LimmaTech Biologics AG have entered into a strategic partnership and exclusive licensing agreement for the development, manufacturing and commercialization of Shigella4V (S4V), a tetravalent bioconjugate vaccine candidate against shigellosis.
-
NewsComprehensive meta-analysis pinpoints what vaccination strategies different countries should adopt
A new paper offers the first comprehensive meta-analysis examining what types of vaccine intervention strategies have the greatest effect, and whether different intervention strategies work better in different countries.
-
NewsShared geographic origin of TB strain and human host could boost risk of infection
For some forms of tuberculosis, the chances that an exposed person will get infected depend on whether the individual and the bacteria share a hometown, according to a study comparing how different strains move through mixed populations in cities.
-
NewsSuper cally molecules take down tuberculosis
Researchers have identified and synthesised a group of molecules that can act against the cause of tuberculosis in a new way. The callyaerins act against TB by employing a fundamentally different mechanism compared to antibiotic agents used to date.
-
NewsGut microbes implicated in bladder cancer
A new study shows that gut bacteria can metabolise carcinogens and cause them to accumulate in distant organs, leading to tumour development.
-
NewsHuman clinical study launched using phage lysin to eliminate staph in the nasal microbiome
A “first-in-human” study with the novel drug candidate HY-133 began on 10 July with the recruitment of clinically healthy volunteers who tested positive for Staphylococcus aureus colonisation of the nose.
-
NewsResearchers find new way to turn bacteria into cellulose-producing mini-factories
A new approach to turning microorganisms into living mini-factories has been developed, allowing scientists to produce tens of thousands of variants of the bacterium very quickly.
-
NewsIncidence of heart attacks and strokes found to be lower after COVID-19 vaccination
A new study involving nearly the whole adult population of England has found that the incidence of heart attacks and strokes was lower after COVID-19 vaccination than before or without vaccination.
-
NewsScientists untangle interactions between the Earth’s early life forms and the environment over 500 million years
A new perspective explores the intricate feedbacks among ancient life forms, including algae, plants and animals, and the chemical environment in the current Phanerozoic Eon, which began approximately 540 million years ago.
-
News‘Russian doll’ packaging could boost drug delivery
Researchers have developed a new technology that lets them create compartments within compartments on the nanoscale, which can mean timing drug release for maximum effect at the site where it’s most needed.
